Global Diagnostic Imaging Agent Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Diagnostic Imaging Agent market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Diagnostic Imaging Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Diagnostic Imaging Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Diagnostic Imaging Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Diagnostic Imaging Agent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Diagnostic Imaging Agent include GE HealthCare, Bracco Diagnostic, Guerbet, Abx Advanced Biochemical, Bayer AG, Blue Earth Diagnostics, Cardinal Health, Eli Lilly and Company and Lantheus, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Diagnostic Imaging Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Diagnostic Imaging Agent, also provides the sales of main regions and countries. Of the upcoming market potential for Diagnostic Imaging Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diagnostic Imaging Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Diagnostic Imaging Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Diagnostic Imaging Agent sales, projected growth trends, production technology, application and end-user industry.

Diagnostic Imaging Agent Segment by Company

GE HealthCare
Bracco Diagnostic
Guerbet
Abx Advanced Biochemical
Bayer AG
Blue Earth Diagnostics
Cardinal Health
Eli Lilly and Company
Lantheus
Mallinckrodt
Navidea
Yantai Dongcheng
Foshan Rui Diao Pharmaceutical
Jubilant Pharma Limited
Diagnostic Imaging Agent Segment by Type

Conjugated Imaging Agent
Metabolic Imaging Agent
Blood Flow and Blood Volume Imaging Agents
Diagnostic Imaging Agent Segment by Application

Neurological Disease
Gastrointestinal Disease
Heart Disease
Tumor
Diagnostic Imaging Agent Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Imaging Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Imaging Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Imaging Agent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diagnostic Imaging Agent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Imaging Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diagnostic Imaging Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Diagnostic Imaging Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Diagnostic Imaging Agent Market Size, 2020 VS 2024 VS 2031
1.3 Global Diagnostic Imaging Agent Market Size Estimates and Forecasts (2020-2031)
1.4 Global Diagnostic Imaging Agent Sales Estimates and Forecasts (2020-2031)
1.5 Global Diagnostic Imaging Agent Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Diagnostic Imaging Agent Market Dynamics
2.1 Diagnostic Imaging Agent Industry Trends
2.2 Diagnostic Imaging Agent Industry Drivers
2.3 Diagnostic Imaging Agent Industry Opportunities and Challenges
2.4 Diagnostic Imaging Agent Industry Restraints
3 Diagnostic Imaging Agent Market by Manufacturers
3.1 Global Diagnostic Imaging Agent Revenue by Manufacturers (2020-2025)
3.2 Global Diagnostic Imaging Agent Sales by Manufacturers (2020-2025)
3.3 Global Diagnostic Imaging Agent Average Sales Price by Manufacturers (2020-2025)
3.4 Global Diagnostic Imaging Agent Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Diagnostic Imaging Agent Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Diagnostic Imaging Agent Manufacturers, Product Type & Application
3.7 Global Diagnostic Imaging Agent Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Diagnostic Imaging Agent Market CR5 and HHI
3.8.2 Global Top 5 and 10 Diagnostic Imaging Agent Players Market Share by Revenue in 2024
3.8.3 2024 Diagnostic Imaging Agent Tier 1, Tier 2, and Tier 3
4 Diagnostic Imaging Agent Market by Type
4.1 Diagnostic Imaging Agent Type Introduction
4.1.1 Conjugated Imaging Agent
4.1.2 Metabolic Imaging Agent
4.1.3 Blood Flow and Blood Volume Imaging Agents
4.2 Global Diagnostic Imaging Agent Sales by Type
4.2.1 Global Diagnostic Imaging Agent Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Diagnostic Imaging Agent Sales by Type (2020-2031)
4.2.3 Global Diagnostic Imaging Agent Sales Market Share by Type (2020-2031)
4.3 Global Diagnostic Imaging Agent Revenue by Type
4.3.1 Global Diagnostic Imaging Agent Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Diagnostic Imaging Agent Revenue by Type (2020-2031)
4.3.3 Global Diagnostic Imaging Agent Revenue Market Share by Type (2020-2031)
5 Diagnostic Imaging Agent Market by Application
5.1 Diagnostic Imaging Agent Application Introduction
5.1.1 Neurological Disease
5.1.2 Gastrointestinal Disease
5.1.3 Heart Disease
5.1.4 Tumor
5.2 Global Diagnostic Imaging Agent Sales by Application
5.2.1 Global Diagnostic Imaging Agent Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Diagnostic Imaging Agent Sales by Application (2020-2031)
5.2.3 Global Diagnostic Imaging Agent Sales Market Share by Application (2020-2031)
5.3 Global Diagnostic Imaging Agent Revenue by Application
5.3.1 Global Diagnostic Imaging Agent Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Diagnostic Imaging Agent Revenue by Application (2020-2031)
5.3.3 Global Diagnostic Imaging Agent Revenue Market Share by Application (2020-2031)
6 Global Diagnostic Imaging Agent Sales by Region
6.1 Global Diagnostic Imaging Agent Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Diagnostic Imaging Agent Sales by Region (2020-2031)
6.2.1 Global Diagnostic Imaging Agent Sales by Region (2020-2025)
6.2.2 Global Diagnostic Imaging Agent Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Diagnostic Imaging Agent Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Diagnostic Imaging Agent Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Diagnostic Imaging Agent Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Diagnostic Imaging Agent Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Diagnostic Imaging Agent Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Diagnostic Imaging Agent Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Diagnostic Imaging Agent Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Diagnostic Imaging Agent Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Diagnostic Imaging Agent Revenue by Region
7.1 Global Diagnostic Imaging Agent Revenue by Region
7.1.1 Global Diagnostic Imaging Agent Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Diagnostic Imaging Agent Revenue by Region (2020-2025)
7.1.3 Global Diagnostic Imaging Agent Revenue by Region (2026-2031)
7.1.4 Global Diagnostic Imaging Agent Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Diagnostic Imaging Agent Revenue (2020-2031)
7.2.2 North America Diagnostic Imaging Agent Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Diagnostic Imaging Agent Revenue (2020-2031)
7.3.2 Europe Diagnostic Imaging Agent Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Diagnostic Imaging Agent Revenue (2020-2031)
7.4.2 Asia-Pacific Diagnostic Imaging Agent Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Diagnostic Imaging Agent Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Diagnostic Imaging Agent Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 GE HealthCare
8.1.1 GE HealthCare Comapny Information
8.1.2 GE HealthCare Business Overview
8.1.3 GE HealthCare Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 GE HealthCare Diagnostic Imaging Agent Product Portfolio
8.1.5 GE HealthCare Recent Developments
8.2 Bracco Diagnostic
8.2.1 Bracco Diagnostic Comapny Information
8.2.2 Bracco Diagnostic Business Overview
8.2.3 Bracco Diagnostic Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio
8.2.5 Bracco Diagnostic Recent Developments
8.3 Guerbet
8.3.1 Guerbet Comapny Information
8.3.2 Guerbet Business Overview
8.3.3 Guerbet Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Guerbet Diagnostic Imaging Agent Product Portfolio
8.3.5 Guerbet Recent Developments
8.4 Abx Advanced Biochemical
8.4.1 Abx Advanced Biochemical Comapny Information
8.4.2 Abx Advanced Biochemical Business Overview
8.4.3 Abx Advanced Biochemical Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio
8.4.5 Abx Advanced Biochemical Recent Developments
8.5 Bayer AG
8.5.1 Bayer AG Comapny Information
8.5.2 Bayer AG Business Overview
8.5.3 Bayer AG Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Bayer AG Diagnostic Imaging Agent Product Portfolio
8.5.5 Bayer AG Recent Developments
8.6 Blue Earth Diagnostics
8.6.1 Blue Earth Diagnostics Comapny Information
8.6.2 Blue Earth Diagnostics Business Overview
8.6.3 Blue Earth Diagnostics Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio
8.6.5 Blue Earth Diagnostics Recent Developments
8.7 Cardinal Health
8.7.1 Cardinal Health Comapny Information
8.7.2 Cardinal Health Business Overview
8.7.3 Cardinal Health Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Cardinal Health Diagnostic Imaging Agent Product Portfolio
8.7.5 Cardinal Health Recent Developments
8.8 Eli Lilly and Company
8.8.1 Eli Lilly and Company Comapny Information
8.8.2 Eli Lilly and Company Business Overview
8.8.3 Eli Lilly and Company Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio
8.8.5 Eli Lilly and Company Recent Developments
8.9 Lantheus
8.9.1 Lantheus Comapny Information
8.9.2 Lantheus Business Overview
8.9.3 Lantheus Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Lantheus Diagnostic Imaging Agent Product Portfolio
8.9.5 Lantheus Recent Developments
8.10 Mallinckrodt
8.10.1 Mallinckrodt Comapny Information
8.10.2 Mallinckrodt Business Overview
8.10.3 Mallinckrodt Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Mallinckrodt Diagnostic Imaging Agent Product Portfolio
8.10.5 Mallinckrodt Recent Developments
8.11 Navidea
8.11.1 Navidea Comapny Information
8.11.2 Navidea Business Overview
8.11.3 Navidea Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Navidea Diagnostic Imaging Agent Product Portfolio
8.11.5 Navidea Recent Developments
8.12 Yantai Dongcheng
8.12.1 Yantai Dongcheng Comapny Information
8.12.2 Yantai Dongcheng Business Overview
8.12.3 Yantai Dongcheng Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio
8.12.5 Yantai Dongcheng Recent Developments
8.13 Foshan Rui Diao Pharmaceutical
8.13.1 Foshan Rui Diao Pharmaceutical Comapny Information
8.13.2 Foshan Rui Diao Pharmaceutical Business Overview
8.13.3 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio
8.13.5 Foshan Rui Diao Pharmaceutical Recent Developments
8.14 Jubilant Pharma Limited
8.14.1 Jubilant Pharma Limited Comapny Information
8.14.2 Jubilant Pharma Limited Business Overview
8.14.3 Jubilant Pharma Limited Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio
8.14.5 Jubilant Pharma Limited Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Diagnostic Imaging Agent Value Chain Analysis
9.1.1 Diagnostic Imaging Agent Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Diagnostic Imaging Agent Production Mode & Process
9.2 Diagnostic Imaging Agent Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Diagnostic Imaging Agent Distributors
9.2.3 Diagnostic Imaging Agent Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings